REQUEST A DEMO
Total
USD $0.00
Search more companies

Zez(Sg) Biotech Pte. Ltd. (Singapore)

Main Activities: Wholesale Trade
Secondary Activities: Biological Product (except Diagnostic) Manufacturing
Full name: Zez(Sg) Biotech Pte. Ltd. Profile Updated: August 14, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Zez(Sg) Biotech Pte. Ltd. is based in Singapore, with the head office in Singapore. It operates in the Wholesale Trade industry. The company was established on May 05, 2021. It currently has a total number of Below 50 (estimated) employees. In 2025, the company reported a net sales revenue drop of 65.27%. Its’ total assets recorded a negative growth of 56.06%. The net profit margin of Zez(Sg) Biotech Pte. Ltd. increased by 0.56% in 2025.

Legal Address
105 Cecil Street, #24-01, The Octagon, Singapore 069534
Singapore; Singapore; Postal Code: 069534

Contact Details: Purchase the Zez(Sg) Biotech Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Zez(Sg) Biotech Pte. Ltd. report to view the information.
Registered Capital:
Purchase the Zez(Sg) Biotech Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Zez(Sg) Biotech Pte. Ltd. report to view the information.
Incorporation Date:
May 05, 2021
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Zez(Sg) Biotech Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
-65.27%
Total Operating Revenue
-65.27%
Net Profit/Loss for the Period
-56.7%
Total Assets
-56.06%
Total Equity
7.64%
Net Profit Margin
0.56%
Return on Equity (ROE)
-10.54%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?